Interesting article ...
Interesting about Telmisartan not being banned ... yet.
Chronic administration of telmisartan remarkably prevented weight gain, enhanced running endurance and post-exercise oxygen consumption, and increased slow-twitch skeletal muscle fibres in wild-type mice.
Telmisartan is a prescription drug for high blood pressure. Itâ€™s accepted by the U.S. Food and Drug Administration and not on the WADA list, nor is the class of drugs to which it belongs. Only specifically named substances and substances that are not approved by government regulatory bodies are on that list.
Telmisartan is neither and, according to recent research by Fabian Sanchis Gomar of the University of Valencia, Spain, it has virtually the same specifics as AICAR and GW1516. It also enhances running ability in mice if they are completely untrained. With training, endurance increases, fat is burnt and recovery is faster as there is less lactic acid formation.
Both WADA and the Dutch anti-doping authority know of Telmisartan but they say they are not convinced of the effects reported by the study by Sanchis-Gomar. â€œRecent scientific research does not seem to validate that claim,â€ WADA spokesmen Oâ€™Rorke insisted.
Herman Ram added that there is a thin line between what is admissible and what not. â€œIn the end everything has an effect on something. So far there hasnâ€™t been a reason to take a closer look on Telmisartan in this respect.â€
Meanwhile, the substance has been found near cycling. During the same Tour de France raid in 2009 the AFLD-researchers found packages of Telmisartan. This was before research claimed similar characteristics as AICAR, and AFLD therefore couldnâ€™t really explain its presence in a cycling-related environment.